Related Experiment Video
Updated: Sep 13, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Aureobasidium Melanogenum as an Uncommon Pathogen Causing Skin and Soft Tissue Infection: A Case Report and
Gopi Patel1, Shelly Sclater1, Pooja Gurram1
1Infectious Diseases, University of Florida, Gainesville, USA.
None:
Aureobasidium melanogenum is an emerging pathogen of growing importance in medical literature. It is a dematiaceous fungus with a propensity to cause opportunistic infections in immunocompromised hosts. However, we present a case of an immunocompetent patient who developed a skin and soft-tissue infection caused by A. melanogenum. The pathogen was identified at a reference laboratory at the University of Texas (UT), San Antonio, Texas, using phenotypic and DNA sequencing techniques. The patient was successfully treated with a two-week course of intravenous micafungin. This case highlights the need to recognize such emerging organisms as potential causes for common community-acquired infections requiring prompt treatment rather than considering them as potential environmental contaminants.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Bacterial Phylum Actinobacteria
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Fungal Phylum Microsporidia

